Corrigendum to: Persistence of biologic treatments in psoriatic arthritis: a population-based study in Sweden

Rheumatol Adv Pract. 2021 Feb 12;5(1):rkab005. doi: 10.1093/rap/rkab005. eCollection 2021.

Authors

Kirk Geale^{1

2}, Ingrid Lindberg¹, Emma C Paulsson¹, E Christina M Wennerström^{3

4}, Anna Tjärnlund³, Wim Noel⁵, Dana Enkusson³, Elke Theander³

Affiliations

¹ Quantify Research, Stockholm.
² Department of Public Health and Clinical Medicine, Umeå University, Umeå.
³ Janssen-Cilag AB, Solna, Sweden.
⁴ Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
⁵ Janssen Pharmaceutica NV, Beerse, Belgium.

Abstract

[This corrects the article DOI: 10.1093/rap/rkaa070.][This corrects the article DOI: 10.1093/rap/rkaa070.].

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.

Publication types

Published Erratum